SCHEMBL8969041

SCHEMBL8969041

COc1cccc2c1CC(CNCCCNS(=O)(=O)c1ccc(F)cc1)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.51
CHRM1 P11229 2/20 0.51
CHRM3 P20309 2/20 0.51
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
DRD3 P35462 1/20 0.47
MTNR1A P48039 6/20 0.44
MTNR1B P49286 6/20 0.44
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP1A2 P05177 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970432 0.84 CHRM2 (0.48) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970496 0.83 CHRM2 (0.48) CHRM2CHRM1CHRM3DRD2DRD3
SCHEMBL9533770 0.82 DRD2 (0.53) HTR1ADRD2DRD4ADRA1DADRA1A
Hydrochloric Acid SCHEMBL9243922 0.81 DRD2 (0.52) HTR1ADRD2DRD4ADRA1DADRA1A
SCHEMBL8970649 0.81 BACE1 (0.47) CHRM2CHRM1CHRM3HTR1ADRD2
SCHEMBL8970546 0.80 DRD2 (0.43) CHRM2CHRM1CHRM3HTR1ADRD2
SCHEMBL9239130 0.78 MTNR1A (0.46) HTR1ADRD2DRD4ADRA1DADRA1A
Hydrochloric Acid SCHEMBL9242599 0.77 MTNR1A (0.46) HTR1ADRD2DRD4ADRA1DADRA1A
SCHEMBL8970407 0.77 SIGMAR1 (0.53) CHRM2CHRM1CHRM3HTR1ADRD2
SCHEMBL8972304 0.75 MTNR1A (0.49) CHRM2CHRM1CHRM3DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed